Skip to main content
SpringerLink
Log in

The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The interaction between cholecystokinin and endogenous opioid systems on rewarding responses was examined. Motivational effects induced by peripheral administration of a complete inhibitor of enkephalin catabolism, RB 101 or the CCKB antagonist PD-134,308, and by both compounds in combination were evaluated in the conditioned place preference test in rats. RB 101 (5, 10, 20, 40 and 80 mg/kg, IP, and 20 mg/kg, IV) given alone produced a bell-shaped dose-effect function. A significant increase of the preference for the drug-associated compartment was only observed at doses of 10 and 20 mg/kg (IP). The effect observed with morphine was stronger, and all the doses used of this compound (1.25, 2.5 and 5 mg/kg, SC) were found to be active. These results suggest that the inhibitor of enkephalin catabolism has weak rewarding properties. Pretreatment with the CCKB antagonist PD-134,308 (0.1, 0.3, 1 and 3 mg/kg, IP) alone failed to produce a reliable aversion or preference on the paradigm studied. When PD-134,308 (0.3 mg/kg, IP) was coadministered with a subthreshold dose of morphine (0.6 mg/kg, SC) or RB 101 (5 mg/kg, IP), a conditioned place preference was observed, indicating that the CCKB antagonist facilitated the motivational responses induced by endogenous enkephalins as compared to morphine. This suggests that endogenous cholecystokinin, acting through CCKB receptors, modulates the rewarding effects of endogenous enkephalins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Agmo A, Gómez M, Irazabal Y (1994) Enkephalinase inhibition facilitates sexual behavior in the male rat but does not produce conditioned place preference. Pharmacol Biochem Behav 47:771–778

    Google Scholar 

  • Altar CA, Boyar WC, Oei E, Wood PL (1998) Cholecystokinin attenuates basal and drug-induced increases in limbic and striatal dopamine release. Brain Res 460:76–82

    Google Scholar 

  • Amalric M, Cline EJ, Martínez JL Jr, Bloom FE, Koob GF (1987) Rewarding properties ofβ-endorphin as measured by conditioned place preference. Psychopharmacology 91:14–19

    Google Scholar 

  • Baamonde A, Daugé V, Ruiz-Gayo M, Fulga IG, Turcaud S, Fournié-Zaluski MC, Roques BP (1992) Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid d and D1 dopamine receptor stimulation. Eur J Pharmacol 216:157–166

    Google Scholar 

  • Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489–495

    Google Scholar 

  • Bechara A, Van der Kooy (1985) Opposite motivational effects of endogenous opioids in brain and periphery. Nature 314:533–534

    Google Scholar 

  • Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516–517

    Google Scholar 

  • Broekkamp CL, Phillips AG, Cools AR (1979) Stimulant effects of enkephalin microinjections into the dopaminergic A10 area. Nature 278:560562

    Google Scholar 

  • Caine SB, Lintz, R, Koob GF (1993) Intravenous self-administration techniques in animals. In: Sahgal A (ed) Behavioral neuroscience: a practical approach. Oxford University Press, Oxford, pp 54–62

    Google Scholar 

  • Crawley JN (1992) Subtype-selective cholecystokinin receptor antagonist block cholecystokinin modulation of dopaminemediated behaviors in the rat mesolimbic pathways. J Neurosci 12:3380–3391

    Google Scholar 

  • Crawley JN, Hommer DW, Skirboll LK (1985) Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion. Brain Res 355:320–330

    Google Scholar 

  • D'Amour FE, Smith DL. (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79

    Google Scholar 

  • Daugé V, Steimes P, Derrien M, Beau N, Roques BP, Feger J (1989) CCK-8 effects on motivational and emotional states of rat involve CCK-A receptors of the postero-median part of the nucleus accumbens. Pharmacol Biochem Behav 34:157–163

    Google Scholar 

  • Daugé V, Kalivas PW, Duffy T, Roques BP (1992) Effects of inhibiting enkephalin catabolism in VTA on motor activity and extracellular dopamine. Brain Res 599:209–214

    Google Scholar 

  • Derrien M, Durieux C, Roques BP (1994) Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole. Br J Pharmacol 111:956–960

    Google Scholar 

  • Faris P, Komisaruk BR, Watkins LR, Mayer D (1983) Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219:310–312

    Google Scholar 

  • File SE (1986) Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav Brain Res 21:189–194

    Google Scholar 

  • Fournié-Zaluski MC, Coric P, Turcaud S, Lucas E, Noble F, Maldonado R, Roques BP (1992) Mixed-inhibitor prodrug as a new approach towards systemically active inhibitors of enkephalin degrading enzymes. J Med Chem 35:2473–2481

    Google Scholar 

  • Funada M, Suzuki T, Narita M, Misawa M, Nagase H (1993) Blockade of morphine reward through the activation of k-opioid receptors in mice. Neuropharmacology 32:1315–1323

    Google Scholar 

  • Gall C, Lauterborn J, Burks D, Serogy K (1987) Co-localization of enkephalins and cholecystokinin in discrete areas of rat brain. Brain Res 403:403–408

    Google Scholar 

  • Glimcher PW, Giavino AA, Margolin DH, Hoebel BG (1984) Endogenous opiate reward induced by an enkephalinase inhibitor, thiorphan, injected into the ventral midbrain. Behav Neurosci 98:262–268

    Google Scholar 

  • Hand TH, Franklin KBJ (1985) 6-OHDA lesions of the ventral tegmental area block morphine-induced but not amphetamineinduced facilitation of self-stimulation. Brain Res 328:233–241

    Google Scholar 

  • Hernando F, Fuentes JA, Roques BP, Ruiz-Gayo M (1994) The CCKB receptor antagonist L-365,260 elicits antidepressant-type effects in the forced-swim test in mice. Eur J Pharmacol 261:257–263

    Google Scholar 

  • Higgins GA, Nguyen P, Seller EM (1991) Blockade of morphine conditioning by the CCKA receptor antagonist devazepide. Eur J Pharmacol 197:229–230

    Google Scholar 

  • Higgins GA, Nguyen P, Seller EM (1992) Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. Brain Res 572:208–215

    Google Scholar 

  • Hökfelt T, Rehfeld JF, Skirboll LR, Ivemark B, Goldstein M, Markey K (1980) Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 285:476–478

    Google Scholar 

  • Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN (1990) Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA 87:6728–6732

    Google Scholar 

  • Koob GF, Goeders NE (1989) Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 214–263

    Google Scholar 

  • Ladurelle N, Keller G, Roques BP, Daugé V (1993) Effects of CCK8 and of the CCK B-selective agonist BC264 on extracellular dopamine content in the anterior and posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res 628:254–262

    Google Scholar 

  • Maldonado R, Derrien M, Noble F, Roques BP (1993) Association of a peptidase inhibitor and a CCK-B antagonist strongly potentiates antinociception mediated by endogenous enkephalins. Neuroreport 7:947–950

    Google Scholar 

  • Maldonado R, Valverde O, Turcaud S, Fournié-Zaluski MC and Roques BP (1994) Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation. Pain 58:77–83

    Google Scholar 

  • Mucha RF, Herz A (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280

    Google Scholar 

  • Mucha RF, Van der Kooy D, O'Shaughnessy M, Bucenieks P (1982) Drug reinforcement studied by use of place conditioning in rat. Brain Res 243:91–105

    Google Scholar 

  • Noble F, Soleilhac JM, Soroca-Lucas E, Turcaud S, Fournié-Zaluski MC, Roques BP (1992a) Inhibition of the enkephalin catabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats. J Pharmacol Exp Ther 261:181–187

    Google Scholar 

  • Noble F, Turcaud S, Fournié-Zaluski MC, Roques BP (1992b) Repeated systemic administration of the mixed of enkephalin-degrading enzymes, RB 101, does not induce either antinociceptive tolerance or cross-tolerance with morphine. Eur J Pharmacol 223:83–89

    Google Scholar 

  • Noble F, Coric P, Furnié-Zaluski MC, Roques BP (1992c) Lack of physical dependence in mice after repeated systemic administration of the mixed inhibitor prodrug of enkephalin-degrading enzymes, RB 101. Eur J Pharmacol 223:94–96

    Google Scholar 

  • Noble F, Fournié-Zaluski MC, Roques BP (1993) Unlike morphine the endogenous enkephalins protected by Rb 101 are unable to establish a conditioned place preference in mice. Eur J Pharmacol 230:139–149

    Google Scholar 

  • Pettit HO, Batsell WR Jr, Mueller K (1989) Triazolam attenuates amphetamine but not morphine conditioned place preferences. Psychopharmacology 98:483–486

    Google Scholar 

  • Pohl M, Benoliel JJ, Bourgoin S, Lombard MC, Mauborgne A, Taquet H, Carayon A, Besson JM, Cesselin F, Hamon M (1990) Regional distribution of calcitonin gene-related peptide-, subtance P-, cholecystokinin-, Met5-enkephalin, and dynorphin A (1–8) like materials in the spinal cord and dorsal root ganglia of adults rats. Effects of dorsal rhizotomy and neonatal capsaicin. J Neurochem 55:1122–1130

    Google Scholar 

  • Roques BP, Daugé V, Gacel G, Fournié-Zaluski MC (1986) Selective agonists and antagonists of delta opioid receptors and inhibitors of enkephalins metabolism. Potential use in treatment of mental illness. Biol Psychiatry 7:287–289

    Google Scholar 

  • Roques BP, Noble F, Daugé V, Fournié-Zaluski MC, Beaumont A (1993) Neural endopeptidase 24.11: structure, inhibition and experimental and clinical pharmacology. Pharmacol Rev 45:87–146

    Google Scholar 

  • Ruiz-Gayo M, Baamonde A, Turcaud S, Fournié-Zaluski MC, Roques BP (1992a) In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin degrading enzymes by RB 101 inhibits [3H]diprenorphine binding. Brain Res 571:306–312

    Google Scholar 

  • Ruiz-Gayo M, Durieux C, Fournié-Zaluski MC, Roques BP (1992b) Stimulation of delta opioid receptors reduces the in vivo binding of the CCKB selective agonist [3H]pBC 264: evidence for a physiological regulation of CCKergic system by endogenous enkephalins. J Neurochem 59:1805–1811

    Google Scholar 

  • Shippenberg TS, Herz, A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ-and k-opioid agonist. Brain Res 436:169–172

    Google Scholar 

  • Shippenberg TS, Bals-Kubik R, Herz A (1993) Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs D-2 dopamine receptors. J Pharmacol Exp Ther 265:53–59

    Google Scholar 

  • Smadja C, Maldonado R, Turcaud S, Fournié-Zaluski, MC, Roques BP (1995) Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalins antidepressant-like effects. Psychopharmacology 120:400–408

    Google Scholar 

  • Suzuki T, Yoshiike M, Funada M, Mizoguchi H, Kamei J, Misawa M (1993) Effect of cyclosporine A on the morphine-induced place preference Neurosci Lett 160:159–162

    Google Scholar 

  • Swerdlow NR, Gilbert D, Koob GF (1989) Conditioned drug effects on spatial preference. Critical evaluation. In: Boulton AA, Baker GB, Greenshaw AJ Neuromethods (Psychopharmacology, vol. 13). Humana Press, New York, pp 399–446

    Google Scholar 

  • Valverde O, Maldonado R, Fournié-Zaluski MC, Roques BP (1994) Cholecystokinin B antagonists strongly potentiate antinociception mediated by endogenous enkephalins. J Pharmacol Exp Ther 270:77–88

    Google Scholar 

  • Wise RA (1980) Action of drugs of abuse on brain reward system. Pharmacol Biochem Behav 13:213–223

    Google Scholar 

  • Zimmermann M (1983) Guest editorial. Pain 16:109–110

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Départment de Pharmacologie Moléculaire et Structurale, U266 INSERM, URA D 1500 CNRS, URF des Sciences, Pharmaceutiques et Biologiques, Faculté de Pharmacie 4, Avenue de l'Observatoire, 75270, Paris Cedex 06, France

    O. Valverde, M. C. Fournié-Zaluski, B. P. Roques & R. Maldonado

Authors
  1. O. Valverde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. C. Fournié-Zaluski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. P. Roques
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R. Maldonado
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valverde, O., Fournié-Zaluski, M.C., Roques, B.P. et al. The CCKB antagonist PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology 123, 119–126 (1996). https://doi.org/10.1007/BF02246168

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246168

Key words

Search

Navigation